You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Comparison of drug holiday from adhd in taiwan and international experience
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-HPS-066
- By: WU, Tsung Hsien (Taipei City Hospital)
- Co-author(s): Tsung Hsien Wu
- Abstract:
Background
Attention-deficit/hyperactivity disorder (ADHD) is a developmental disorder that affects approximately one in 20 children. Medication is a first-line effective treatment for ADHD. Common options are immediate-release methylphenidate(IR-MPH) 、the osmotic controlled –release formulation of methylphenidate(OROS-MPH), and atomoxetine(ATX).Met..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026